Idorsia Ltd. (IDRSF)

5.30 0.00 (0.00%) USD  |  OTCM  |  Sep 25, 16:00
More

Idorsia Cash from Operations (Annual) : -203.32M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for IDRSF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2025 -203.32M
December 31, 2024 -420.40M
December 31, 2023 -700.27M
December 31, 2022 -899.53M
December 31, 2021 -645.21M
Date Value
December 31, 2020 -388.52M
December 31, 2019 -464.93M
December 31, 2018 -360.51M
December 31, 2017 97.02M
December 31, 2016 -267.30M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Basilea Pharmaceutica AG 74.76M
Santhera Pharmaceuticals Holding AG -41.86M
BeOne Medicines Ltd. 1.131B
AC Immune SA -83.40M
CRISPR Therapeutics AG -345.01M